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Abstract
Despite the importance of membrane proteins in cellular processes, studies of these hydrophobic proteins present major 
technical challenges, including expression and purification for structural and biophysical studies. A modified strategy of that 
proposed previously by Saidijam et al. (2005) and others, for the routine expression of bacterial membrane proteins involved 
in environmental sensing and antimicrobial resistance (AMR), is proposed which results in purification of sufficient proteins 
for biophysical experiments. We report expression successes amongst a collection of enterococcal vancomycin resistance 
membrane proteins:  VanTG,  VanTG-M transporter domain, VanZ and the previously characterised VanS (A-type) histidine 
protein kinase (HPK). Using the same strategy, we report on the successful amplification and purification of intact BlpH 
and ComD2 HPKs of Streptococcus pneumoniae. Near-UV circular dichroism revealed both recombinant proteins bound 
their pheromone ligands BlpC and CSP2. Interestingly, CSP1 also interacted with ComD. Finally, we evaluate the alterna-
tive strategy for studying sensory HPKs involving isolated soluble sensory domain fragments, exemplified by successful 
production of  VicKESD of Enterococcus faecalis VicK. Purified  VicKESD possessed secondary structure post-purification. 
Thermal denaturation experiments using far-UV CD, a technique which can be revealing regarding ligand binding, revealed 
that: (a)  VicKESD denaturation occurs between 15 and 50 °C; and (b) reducing conditions did not detectably affect denatura-
tion profiles suggesting reducing conditions per se are not directly sensed by  VicKESD. Our findings provide information on 
a modified strategy for the successful expression, production and/or storage of bacterial membrane HPKs, AMR proteins 
and sensory domains for their future crystallisation, and ligand binding studies.
Keywords Histidine kinase · Membrane proteins · Vancomycin resistance · Enterococci · Pheromone sensors · 
Streptococcus pneumoniae · Circular dichroism spectroscopy · Analytical ultracentrifugation
Abbreviations
AMR  Antimicrobial resistance
HPK  Histidine protein kinase
ESD  Extracellular sensing domain
LB  Luria–Bertani broth
IPTG  Isopropyl β-d-1-thiogalactoside
DDM  N-dodecyl β-d-maltoside
Introduction
Membrane proteins are crucially important for the physi-
ological functioning of biological cells, possessing roles in 
molecular recognition and signal transduction, transport of 
essential nutrients, exclusion of toxic molecules, ion regula-
tion and energy generation. Between 20 and 30% of proteins 
encoded by eubacterial, archaeon and eukaryotic genomes 
Special Issue: 23rd International AUCWorkshop and Symposium.
 * Mary K. Phillips-Jones 
 sbamp5@exmail.nottingham.ac.uk
1 AMR Biophysics Group, School of Pharmacy 
and Biomedical Sciences, University of Central Lancashire, 
Preston, Lancashire PR1 2HE, UK
2 Astbury Centre for Structural Molecular Biology, Faculty 
of Biological Sciences, University of Leeds, Leeds LS2 9JT, 
UK
3 Department of Pharmaceutical, Chemical and Environmental 
Sciences, University of Greenwich, Central Avenue, 
Chatham, Kent ME4 4TB, UK
4 National Centre for Macromolecular Hydrodynamics, School 
of Biosciences, University of Nottingham, Sutton Bonington, 
Loughborough, Leicestershire LE12 5RD, UK
 European Biophysics Journal
1 3
are membrane proteins (Wallin and von Heijne 1998), and 
in humans defects in their proper folding or other mutations 
can result in many serious diseases. Approximately, 60% 
of current small molecule drugs target membrane proteins 
(Terstappen and Reggiani 2001; Davey 2004; Arinaminpa-
thy et al. 2009), testifying to the potential of identifying 
further membrane proteins as new drug targets in the future. 
Knowledge of the three-dimensional structure of membrane 
proteins coupled with how they function is one important 
area for drug discovery goals. But largely due to their hydro-
phobicity, membrane proteins pose technical challenges for 
their expression and purification and for structural work 
such as crystallisation. As a result, only approximately 2% 
of protein structures in the Protein Data Bank (PDB) are 
membrane proteins (http://blanc o.biomo l.uci.edu/mpstr uc/; 
Miles and Wallace 2016).
Yet, there have been recent advances in methods for the 
production of low abundance membrane proteins, including 
bacterial membrane proteins (e.g. Potter et al. 2002; and 
reviewed in Saidijam et al. 2003, 2005; Suzuki and Hender-
son 2006; Moraes et al. 2014; Hardy et al. 2016; Hussain 
et al. 2016; Lee et al. 2016; Lee and Pollock 2016; Rawl-
ings 2016), leading to increased successes in crystallisation, 
structural determination and in elucidation of mechanisms 
of action (e.g. Weyand et al. 2008; Shimamura et al. 2010; 
Simmons et al. 2014). Many of the expression and purifica-
tion strategies for bacterial membrane proteins are based on 
work with highly hydrophobic membrane transport proteins 
(Ward et al. 1999; Saidijam et al. 2005; Suzuki and Hender-
son 2006). Here, we present an adapted strategy based on 
these established methods for reliable production of mem-
brane histidine protein kinases (HPKs) of bacterial two-
component signal transduction systems (Potter et al. 2002; 
Ma et al. 2008) and a variety of other membrane proteins 
involved in antimicrobial resistances (AMR) and peptide 
pheromone sensing, described below.
Resistance by bacteria to current antibiotic agents is 
recognised to be a major global problem in the treatment 
of hospital and other infections. Resistance mechanisms 
(which can be considered as nanomachines) mounted by 
bacteria in response to exposure to antibiotic drugs often 
comprise cascades of molecular mechanisms for drug rec-
ognition, signal transduction and production of efflux and/
or deactivation processes to remove the antibiotic threat 
and ensure bacterial survival (Phillips-Jones & Harding 
2018). Many of the components involved in antibacterial 
resistances are membrane proteins. Structural elucidation of 
these components and characterisation of their mechanisms 
of action are important for future intervention strategies. 
Biophysical approaches also provide important information. 
For example, we recently used hydrodynamic methods to 
demonstrate binding by the glycopeptide antibiotic vanco-
mycin to the VanA-type VanS histidine kinase membrane 
receptor (Phillips-Jones et al. 2017a, b). Furthermore, using 
circular dichroism spectroscopy, we showed that glycopep-
tide binding to VanS is weak (Hughes et al. 2017). Intact 
VanS protein was produced for these experiments through 
the commonly used method of heterologous expression of 
a plasmid-borne gene (in this case vanS) in a heterologous 
Escherichia coli host, using a membrane protein overex-
pression plasmid such as pTTQ18His (e.g. Saidijam et al. 
2005). However, modifications to these published strategies 
for expression and purification were necessary to ensure suc-
cess. Furthermore, following VanS purification, reduced or 
no detergent was added for subsequent biophysical experi-
ments to prevent potential inhibition of dimerization and 
phosphorylation activities, as commonly observed for many 
HPK proteins. Here, we evaluate these modifications that 
proved successful for production of active intact VanS, for 
the expression of a collection of HPK and AMR membrane 
proteins of different membrane topologies, and for two spe-
cific examples of peptide pheromone-sensing HPKs (BlpH 
and ComD of Streptococcus pneumoniae (de Saizieu et al. 
2000; Pestova et al. 1996; Cheng et al. 1997; Podbielski & 
Kreikemeyer 2004), including their ligand binding abilities 
post-purification. We compare this adapted strategy with that 
used previously for other Enterococcus faecalis HPKs by 
Ma et al. (2008), who reported the successful expression 
in E. coli of 15 out of 16 of the genome complement of 
membrane HPK genes and the purification of 12 out of the 
15 expressed HPKs. We also investigate another strategy for 
investigations of ligand binding and sensing mechanisms 
using only the predicted sensory domain in isolation; we 
sought to determine whether the soluble extracellular sen-
sory domain of the Enterococcus faecalis VicK histidine 
kinase,  VicKESD, lacking its transmembrane segments can be 
successfully expressed and purified for future characterisa-
tion using biophysical techniques.
Materials and methods
Gene cloning
Genes involved in conferring resistance to glycopeptide 
antibiotics in enterococci
Plasmids were constructed, sequenced and kindly provided 
by Dr Djalal Meziane-Cherif and Professor Patrice Cour-
valin (Pasteur Institute, France). The Enterococcus faeca-
lis BM4518 vanTG (encoding VanG-type serine racemase 
involved in transport and conversion of l-serine to d-serine) 
(AAQ16274.1) and vanTG-M (encoding residues 1–342 of 
 VanTG—the membrane serine transporter component of 
 VanTG) (Meziane-Cherif et al. 2015) were cloned into the 
membrane protein overexpression plasmid pTTQ18His as 
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described in Ma et al. (2008). Cloning and expression of 
the gene encoding the VanA-type VanS membrane histidine 
kinase of E. faecium B4147 has been described previously 
(Phillips-Jones et al. 2017a). The VanA-type vanZ gene of 
E. faecium B4147 (CDD 121006; AAA65959 Arthur et al. 
1995), which confers teicoplanin resistance, was cloned into 
pMR2, a derivative of pTTQ18His, introducing a  His6 tag at 
the N-terminus of the expressed recombinant protein ensur-
ing a predicted location for the  His6 tag on the inside of the 
membrane (Rahman et al. 2007).
Streptococcus pneumoniae ComD and BlpH 
pheromone‑sensing histidine protein kinases
The blpH (de Saizieu et  al. 2000) and comD (Cheng 
et al. 1997; Pestova et al. 1996) genes of S. pneumoniae 
ATCC700669 were amplified by PCR and cloned into 
pTTQ18His as described previously (Ma et al. 2008). The 
comD gene was cloned as a SacI-SalI ended fragment, whilst 
the blpH gene was cloned as an EcoRI-PstI-ended fragment. 
Clones were verified by gene sequencing. An RGS(H)6 
sequence was introduced at the C terminus of both proteins 
to facilitate purification by nickel affinity methods (Ma et al. 
2008).
Extracellular sensing domain of enterococcal VicK
The putative extracellular sensing domain of VicK,  VicKESD 
(equivalent to residues 35–176 of E. faecalis V583 vicK), 
was amplified by PCR and cloned as an NdeI-BamHI frag-
ment into pET14b. The correct sequence was verified by 
DNA sequencing. The expressed protein with an N-terminal 
GSS(H)6SSGLVPRGSHMI sequence was predicted to be 
18,238 Da and this was confirmed by mass spectrometry.
Expression studies
All expression plasmids were transformed into E. coli BL21 
[DE3].
For small-scale expression trials of vancomycin resist-
ance genes, cultures (50 ml) were grown aerobically in 
Luria–Bertani (LB) broth containing 100 μg ml−1 carbeni-
cillin at 37 °C until an absorbance  (A600) of 0.5 was reached 
when 1 mM isopropyl β-d-1-thiogalactoside (IPTG) was 
added for induction of van gene expression (Ward et al. 
1999; Saidijam et al. 2005). Growth was permitted to con-
tinue for a further 3 h post-induction at a reduced tempera-
ture of 30 °C before cell harvesting. No optimisations of 
expression conditions were undertaken. Mixed E. coli mem-
branes were prepared by the water lysis method (Ward et al. 
1999) and samples analysed by SDS-polyacrylamide gel 
electrophoresis and Western blotting (see below).
Expression of S. pneumoniae comD and blpH was under-
taken in large-scale (6 l) culture experiments employing the 
non-optimised strategy described above. Briefly, E. coli 
BL21 [DE3] cells harbouring pTTQcomD or pTTQblpH 
were cultured aerobically in 6 l of selective Luria–Bertani 
(LB) broth at 37 °C and induced with 1 mM IPTG. The 
cultures were incubated for a further 3 h at a reduced tem-
perature of 30 °C prior to cell harvesting. Cells were lysed 
by explosive decompression and mixed membranes prepared 
as described by Ma et al. (2008).
Expression trials of soluble  VicKESD was undertaken 
by cultivation of E. coli BL21 [DE3]/pET14b-VicKESD 
in 500 ml of LB broth containing 100 μg.ml−1 ampicillin 
at 37 °C and induction with 0.4 mM IPTG induction as 
described above for the Van proteins. After incubation for a 
further 3 h at 37 °C, cells were lysed by sonication and the 
insoluble membrane fraction harvested by centrifugation at 
100,000g for 40 min at 4 °C. Separated soluble and insolu-
ble fractions were stored at − 20 °C prior to SDS-PAGE 
analysis.
All growth experiments included control cultures in the 
absence of IPTG (uninduced cultures).
Purification of BlpH, ComD and  VicKESD proteins
For BlpH and ComD membrane proteins, total mixed mem-
branes of E. coli BL21 [DE3] harbouring pTTQblpH or 
pTTQcomD were prepared using methods described previ-
ously (Potter et al. 2002; Ma et al. 2008), except that the 
sucrose density gradient centrifugation step used to sepa-
rate the inner and outer membranes was omitted. His-tagged 
BlpH and ComD proteins were solubilised from mixed 
membranes using 1% (w/v) DDM detergent and purified 
by nickel affinity chromatography as described by Ma et al. 
(2008) using wash buffers containing 20 mM imidazole and 
elution buffers containing 200 mM imidazole, both of which 
contained 0.05% n-dodecyl-β-d-maltoside (DDM) (Saidijam 
et al. 2005). Purified proteins were exchanged into 10 mM 
sodium phosphate, pH 7.2, containing 0.05% DDM.
For purification of  VicKESD protein from soluble cell 
fractions, nickel affinity chromatography was undertaken in 
the absence of DDM, but otherwise according to Ma et al. 
(2008) using wash buffers containing 20 mM imidazole and 
elution buffer comprising 200 mM sodium acetate, pH 4.0. 
Purified protein was exchanged into 20 mM Tris–HCl, pH 
7.9, or 20 mM sodium acetate, pH 4.0, or 20 mM sodium 
phosphate, pH 7.2, or 10 mM ammonium hydrogen carbon-
ate, pH 8.0, using Centricon filter devices.
SDS‑polyacrylamide gel electrophoresis (SDS‑PAGE)
Proteins were separated by SDS-PAGE using 4–5% stacking 
and 12% resolving SDS-polyacrylamide gels prepared and 
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subjected to electrophoresis according to Sambrook et al. 
(1989). For Western blotting experiments, the separated pro-
teins were first electroblotted onto Fluorotrans Transfer mem-
brane (Pall Corp.) as described previously (Ma et al. 2008).
Western blotting
Western blotting experiments to detect the presence of the  His6 
tags of recombinant overexpressed proteins were performed 
using the INDIA™ HisProbe-HRP (Perbio Science UK Ltd) 
with Supersignal West Pico Chemiluminescent substrate 
(Pierce) detection as described previously (Ma et al. 2008).
Mass spectrometry
To confirm the molecular masses of purified  VicKESD and 
VanS, the electrospray ionisation mass spectrometry facility 
of the Astbury Centre for Structural Molecular Biology, Uni-
versity of Leeds, UK, was used (Phillips-Jones et al. 2017a).
N‑terminal sequencing
Purified proteins (VanS and  VicKESD) were transferred to 
Fluorotrans Transfer membrane (Pall Corp.), visualised 
by Coomassie Blue G-250 staining and bands excised for 
sequencing using Edman degradation (Alta Biosciences, Uni-
versity of Birmingham, UK).
Protein determination
Protein determinations were carried out using bicinchoninic 
acid in a Pierce™ BCA Protein Assay Kit (Thermo Scientific) 
according to the manufacturer’s instructions. Bovine serum 
albumin was used as standard.
BlpH and ComD ligands
Mature BlpC, CSP1 and CSP2 peptide ligands were synthe-
sised and verified by Cambridge Peptides (Birmingham, UK) 
and dissolved in 100% acetonitrile.
Peptide
 BlpC N-GLWEDLLYNINRYAHYIT-C
 ComC CSP1 N-EMRLSKFFRDFILQRKK-C
 ComC CSP2 N-EMRISRIILDFLFLRKK-C
Circular dichroism spectroscopy (CD)
CD experiments were performed using a nitrogen-flushed 
Jasco J715 spectropolarimeter (for  VicKESD) or an Applied 
Photophysics Chirascan Plus instrument (for ComD and 
BlpH). Purified membrane proteins were typically prepared 
in 10 mM sodium phosphate, pH 7.2–7.6 (in the presence of 
0.05% DDM for membrane proteins) (Patching et al. 2012; 
Miles and Wallace 2016) and allowed to equilibrate for 
20 min at 15 or 20 °C prior to acquisition of spectral data. A 
bandwidth of 2 nm was used and data acquired at 1 s/nm. No 
data in which the HT of the detector exceeded 600 V were 
included in the analyses.
For CD measurements in the far-UV (180–260 nm), 
protein concentrations in the range 2.4–14.0  μM 
(~ 0.12–0.25 mg ml−1) were employed in sample volumes 
of 200–350 μl using a pathlength of 1 mm. The longer path-
length cell was selected on the basis of the buffer and deter-
gent concentrations used here (Miles and Wallace 2016). 
For  VicKESD measurements at 15 and 37 °C, 30 scans were 
obtained; for thermal denaturation experiments, 5 scans 
were obtained. For BlpH and ComD proteins, spectra are the 
average of two scans. Thermal denaturation experiments for 
 VicKESD were performed at a starting temperature of 15 °C 
which was increased stepwise and incrementally to 90 °C; 
at each step, 10 min equilibration time was permitted before 
acquisition of spectral data.
For CD measurements in the near-UV region 
(250–340  nm), protein concentrations of 3.6  µM 
(0.2 mg ml−1) (ComD) or 9.5 µM (BlpH) were employed 
in sample volumes of 400 µl using a pathlength of 10 mm. 
Spectra shown are the average of ten scans. Reaction mixes 
were incubated with peptide ligands (or equivalent volumes 
of acetonitrile solvent) for 20 min prior to acquisition of 
spectral data as described by Patching et al. (2012).
In all cases, control spectra of buffers with other rel-
evant additives (in the absence of added proteins) were 
also obtained. These spectra were subtracted from spectra 
obtained for each purified protein and used to derive differ-
ence spectra. The maximum concentration of acetonitrile in 
ligand experiments was 0.45%.
Results
Expression of VanS,  VanTG,  VanTG‑M and VanZ 
membrane proteins involved in vancomycin 
resistance
Genes encoding enterococcal vancomycin resistance deter-
minants  VanTG, (a VanG-type serine racemase),  VanSA 
(the VanA-type membrane histidine protein kinase) 
and  VanZA (a membrane protein conferring teicoplanin 
resistance) were cloned into the membrane protein over-
expression plasmid pTTQ18His (vanTG, vanSA) or its 
derivative plasmid pMR2 (vanZA) using the approaches 
described previously for other membrane proteins (Potter 
et al. 2002; Ma et al. 2008; Phillips-Jones et al. 2017a). 
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VanZ has an uneven number (five) of predicted trans-
membrane segments and so its encoding gene was cloned 
into pMR2, which fuses a  His6 tag at the N-terminus of 
the expressed recombinant protein, thereby ensuring that 
upon expression of VanZ, the  His6 tag is located intra-
cellularly. VanS and  VanTG are predicted to possess two 
and ten membrane-spanning segments, respectively. In 
addition, a truncated version of vanTG was also cloned 
into pTTQ18His; residues 1–342 of  VanTG comprise the 
serine transporter domain of the full-length protein and 
hence also possess the ten transmembrane segments of the 
serine transporter but lack the racemase domain (Mezi-
ane-Cherif et al. 2015). The same domain architecture 
and functions have been shown to occur in homologues 
of other Van-type species and strains, including VanC-
type strains (Arias et al. 1999, 2000, 2003; Reynolds & 
Courvalin 2005). Sequence-verified plasmids were trans-
formed into E. coli BL21 [DE3] which was cultured and 
induced for vanTG, vanTG-M, vanS and vanZ expression, 
as described in “Materials and methods”. Figure 1 shows 
SDS-polyacrylamide gel (SDS-PAGE) and Western blot 
analysis of mixed membranes prepared from induced and 
control uninduced cultures. Membranes prepared from 
induced cultures harbouring each expression plasmid, 
pTTQ-vanTG, pTTQ-vanTG-M, pTTQ-vanS and pTTQ-
vanZ, all showed additional bands which gave a positive 
Fig. 1  Expression in E. coli 
BL21 [DE3] mixed membranes 
of intact  His6-tagged vancomy-
cin resistance proteins:  VanTG 
(serine racemace) of E. faecalis 
BM4518,  VanTG-M (residues 
1–342; a truncated version of 
native  VanTG encoding only 
the putative serine membrane 
transporter portion),  VanSA and 
 VanZA of E. faecium B4147. 
Mixed membranes (10 μg) from 
cultures harbouring pTTQ-
vanTG, pTTQ-vanTG-M, pTTQ-
vanSA (Phillips-Jones et al. 
2017a) or pMR2-vanZ (Rahman 
et al. 2007) expression plasmids 
and induced with 1 mM iso-
propylthiogalactoside (IPTG) 
or uninduced cultures carrying 
the same plasmids were loaded 
on SDS-polyacrylamide gels 
(4% stacking/12% resolving). 
Following electrophoresis, 
gels were either stained with 
Coomassie Brilliant Blue for 
visual detection of protein bands 
(uppermost panel) or proteins 
were transferred electropho-
retically onto PVDF membrane 
for Western blotting using an 
INDIA His probe followed by 
exposure to photographic film 
(lowermost panel)
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reaction in the Western blots with the INDIA His probe for 
detection of  His6 tags, indicative of successful expression 
of all four membrane proteins (Fig. 1b).
Additional bands in induced cultures harbouring pTTQ-
vanTG-M and pTTQ-vanS were also visible in the SDS-
PAGE gels (Fig. 1a) indicative of higher levels of overex-
pression. No signals were detected in any of the uninduced 
control membranes, indicating tight regulatory control of 
the ptac promoter of pTTQ18His in the absence of inducer, 
which is consistent with previous observations (Ma et al. 
2008). The predicted masses of the His-tagged proteins are 
81.2 kDa  (VanTG), 38.8 kDa  (VanTG-M), 45.8 kDa (VanS) 
and 20.1 kDa (VanZ). The positive protein bands shown in 
Fig. 1 appear of lower mass than these predicted values. 
This is likely to be due to anomalous migration behaviour 
that is typical of hydrophobic membrane proteins in the 
approximate technique of SDS-PAGE. However, final con-
firmation that the detected protein bands are indeed intact 
 VanTG,  VanTG-M and VanZ would routinely be carried out 
following purification of each protein via mass spectrom-
etry and/or N-terminal sequencing (see Ma et al. 2008 for 
example). Indeed, the intact nature of the VanS protein has 
already been confirmed in our laboratory; VanS was puri-
fied as described in Phillips-Jones et al. (2017a) and a mass 
of 45,775 Da was determined using electrospray ionisa-
tion mass spectrometry (ESI-MS) which closely matches 
the predicted mass of 45,765 Da. Further confirmation 
was provided by sedimentation equilibrium experiments, 
which determined the overall weight average molar mass 
to be 46.4–47.7 kDa (Phillips-Jones et al. 2017a). N-ter-
minal sequencing confirmed the presence of the expected 
n-MNSHM sequence and the protein was shown to retain 
its autophosphorylation activity post-purification (Phillips-
Jones et al. 2017a).
Expression, purification and verification of S. 
pneumoniae BlpH and ComD histidine protein 
kinases
Successful expression of intact BlpH and ComD membrane 
HPKs from S. pneumoniae ATCC 700669 was achieved 
through expression of pTTQ18His-based constructs in E. 
coli BL21 [DE3]. Figure 2 shows samples of mixed mem-
brane preparations of IPTG-induced and -uninduced cul-
tures in which additional bands for both putatively expressed 
proteins are visible in SDS-polyacrylamide gel analysis of 
samples derived from induced cultures. The additional 
bands also give positive signals with the INDIA His probe, 
confirming the presence of His-tagged proteins. Recombi-
nant His-tagged BlpH and ComD have predicted molecu-
lar masses of 53,439 and 52,725 Da, respectively. In com-
mon with the Van proteins described here and indeed many 
other membrane proteins previously, the apparent molecular 
masses of recombinant BlpH and ComD in SDS-PAGE 
appear lower than predicted (Fig. 2). Once again, although 
these proteins require verification that they have remained 
intact post-purification, it is likely that the smaller apparent 
masses are attributable to their anomalous migration behav-
iour in SDS-PAGE as described previously for other hydro-
phobic membrane proteins (Ma et al. 2008; Phillips-Jones 
et al. 2017a, b). That the expressed proteins possess intact 
C-termini was verified by Western blot analysis; positive 
signals were obtained with the His probe that detects the 
Fig. 2  Expression in E.coli BL21 [DE3] mixed membranes of intact 
 His6-tagged BlpH and ComD membrane histidine kinases of Strep-
tococcus pneumoniae. Mixed membranes (20 μg) from cultures har-
bouring pTTQblpH or pTTQcomD and induced with 1 mM iso-pro-
pylthiogalactoside (IPTG) or uninduced cultures carrying the same 
plasmids were loaded on SDS-polyacrylamide gels (4% stacking/12% 
resolving). Following electrophoresis, gels were either stained with 
Coomassie Brilliant Blue for visual detection of protein bands (upper-
most panel) or proteins were transferred electrophoretically onto 
PVDF membrane for Western blotting using an INDIA His probe fol-
lowed by exposure to photographic film (lowermost panel)
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C-terminal hexa-His motif (Fig. 2). The proteins were suc-
cessfully purified using the nickel affinity purification pro-
tocol described in “Materials and methods” (Fig. 3). Purity 
was approximately 93–99% as determined by densitometry 
measurements. 
Ligand binding studies using purified BlpH 
and ComD
Purified BlpH and ComD were used in far-UV CD spectros-
copy experiments to determine whether the purified proteins 
possessed secondary structure following detergent-based 
purification. Figure 4a, c shows spectra for His-tagged BlpH 
and ComD, respectively, obtained in the far-UV region. The 
spectra of both proteins were typical of those for α-helical 
membrane proteins, with spectral minima observed in the 
regions of 208 and 222 nm, confirming possession of struc-
tural integrity in both purified BlpH and ComD post-purifi-
cation (Fig. 4) (Kelly et al. 2005; Patching et al. 2012; Sili-
gardi et al. 2014). The presence of excess synthetic mature 
BlpC pheromone had no significant effect on the secondary 
structural conformation of BlpH (Fig. 4a). Similarly, the 
presence of mature CSP1 or CSP2 exerted no detectable 
effect on ComD secondary structure (Fig. 4c). However, 
near-UV difference spectra in the presence of the BlpC 
pheromone revealed small, but significant spectral changes, 
indicative of changes in tertiary structural conformation and 
confirming interactions between BlpH and BlpC. Spectral 
changes occurred in the 255–270 nm range of Phe side chain 
transitions as well as the 275–282 nm peaks attributable to 
Tyr residues, with a less marked change in the 290–305 nm 
region attributable to Trp. Hence the environments of the 
side chains of Phe, Tyr and to a lesser extent Trp were all 
affected during the tertiary structural changes induced by 
the interaction between BlpH and the BlpC pheromone 
(Fig. 4b). Tertiary structural conformational change in the 
presence of peptide pheromone was also demonstrated in the 
present study for ComD (belonging to pherotype ComD2) 
(Fig. 4d). Near-UV difference spectra in the presence and 
absence of peptide pheromone CSP2 [ComC2; the cognate 
peptide pheromone to which ComD from S. pneumoniae 
ATCC 700669 responds (Croucher et al. 2009)] revealed 
a significant change in the environments of Phe and to a 
lesser extent Tyr residues (Fig. 4d), confirming interactions 
by this known peptide ligand. Interestingly, CSP1 (ComC1) 
also exerted an effect on the near-UV difference spectrum, 
indicative of binding. Indeed, the effect of CSP1 on the 
environment of Phe residues was overall more marked than 
the effect of CSP2, indicating different tertiary structural 
changes in response to each peptide (Fig. 4d).
Cloning, overexpression and purification of  VicKESD, 
the extracellular sensory domain of VicK of E. 
faecalis V583
An alternative strategy to using full-length membrane 
sensor kinases to study sensing mechanisms is to use 
the sensory domains in isolation. To determine whether 
a truncated soluble version of VicK possessing the pre-
dicted sensing domain in isolation could be successfully 
Fig. 3  Purification of 
 His6-tagged BlpH and ComD 
histidine kinases from E. coli 
BL21 [DE3] mixed membranes. 
Nickel affinity methods were 
used as described in “Materials 
and methods” using wash buff-
ers containing 20 mM imidazole 
and elute buffers containing 
200 mM imidazole as described 
in Ma et al. 2008. a SDS-PAGE 
and Coomassie Brilliant Blue 
staining of purified proteins 
(4 μg BlpH and 5 μg ComD); % 
values shown below each lane 
indicate the % purity of each 
protein determined by densi-
tometry. b Western blot analysis 
using 5 μg purified protein
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expressed and purified, the pET14b-VicKESD construct 
described in “Materials and methods” was expressed in 
E. coli BL21 [DE3]. Induction of  VicKESD expression 
was performed through the addition of 0.4 mM IPTG as 
described in “Materials and methods” and cultures were 
then incubated for a further 3 h at 37 °C post-induction 
prior to cell harvesting. Uninduced control cultures 
achieved similar growth rates as induced cultures indicat-
ing that  VicKESD expression is not deleterious to growth 
of E. coli under these conditions (data not shown). Fol-
lowing cell sonication and centrifugation, soluble and 
insoluble fractions were analysed by SDS-polyacrylamide 
gel electrophoresis and Western blotting with His probe 
detection (Fig. 5). Figure 5a shows Coomassie Brilliant 
Blue-stained SDS-polyacrylamide gels of soluble and 
insoluble fractions of IPTG-induced and uninduced cul-
tures. Only the soluble fractions from induced cultures 
showed the presence of an amplified additional visible 
protein band in SDS-polyacrylamide gels at the expected 
position of ~ 18 kDa (Fig. 5a). Western blot analysis of 
these fractions using a His probe to detect the presence 
of the N-terminal  His6 tag is shown in Fig. 5c. Although 
the putative  VicKESD protein was present in all frac-
tions, a greater proportion was found in soluble fractions 
originating from IPTG-induced cultures (Fig. 5c). It is 
interesting to note the presence of putative  VicKESD in 
the uninduced cultures too, possibly indicative of leaky 
vicKESD expression in the absence of inducer using this 
pET14b expression plasmid.  VicKESD was purified from 
soluble fractions to at least 90% purity as described in 
Fig. 4  Characterisation of purified membrane histidine kinases 
BlpH and ComD in 10  mM sodium phosphate pH 7.2 contain-
ing 0.05% DDM in the presence and absence of peptide pheromone 
ligands using CD spectroscopy. Far-UV difference spectra for a BlpH 
(2.4 μM) and c ComD (3.6 μM) are shown for wavelength ranges of 
197–260 nm (BlpH) or 202–260 nm (ComD) using average data of 
two repeats measured in a 1 mm pathlength cell, 2 nm bandwidth and 
1  s/nm at 20  °C. Spectra were set to zero at 255 nm. Near-UV dif-
ference spectra for b BlpH (9.5 µM) in the presence and absence of 
fourfold (38 µM) BlpC peptide pheromone, and d ComD (3.6 µM) in 
the presence and absence of ~ ninefold (~ 32 µM) CSP1 or CSP2 pep-
tide pheromones are shown using averaged data of ten repeat scans 
measured in a 10  mm pathlength cell, 2  nm bandwidth and 1  s/nm 
at 20  °C. Spectra were set to zero at 335 nm. Unsmoothed data are 
shown. For both proteins, difference spectra are shown in which spec-
tral contributions of buffer or other additives have been subtracted
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“Materials and methods” and verified by Western blotting 
(Fig. 5c), N-terminal sequencing (in which the expected 
correct n-GSSHHHH sequence was obtained) and by mass 
spectrometry (in which a mass of 18,255 Da was obtained 
which matches closely the predicted mass of 18,210 Da). 
Purified  VicKESD was exchanged into four different buff-
ers. Any significant insolubility of purified  VicKESD in 
any of these buffers was screened through retention of 
insoluble protein in Centricon filters resulting in reduced 
protein passing through into the filtrate. Figure 5b shows 
no detectable difference in  VicKESD levels in the filtrates 
from all buffers, suggesting that the protein at ~ 19 mg/
ml is equally soluble in all four buffers. The successful 
production of high concentrations of purified  VicKESD is 
therefore established here.
Structural status and thermal denaturation 
studies of  VicKESD investigated using far‑UV CD 
spectroscopy
To firstly determine whether purified  VicKESD possessed 
secondary structure and therefore structural integrity post-
purification, CD spectroscopy in the far-UV region was 
undertaken using 0.25 mg/ml protein. Figure 6a reveals dif-
ference spectral data (200–260 nm with HT values < 600 V), 
consistent with that of an α-helical protein with spectra 
minima at 208 and 222 nm and therefore confirming the 
presence of secondary structure following the purification 
process. The difference spectrum at 15 °C is deeper than that 
obtained at 37 °C, suggesting that  VicKESD exhibits some 
degree of denaturation through loss in secondary structure 
during the incremental temperature ramping steps from 15 to 
37 C (Fig. 6a). Figure 6b shows the spectral minima values 
at 208 and 222 nm during the thermal ramping steps. These 
data suggest that most thermal denaturation occurs pre-
dominantly in a temperature range from 15 to 50 °C. Above 
50 °C and up to 90 °C, there is little further denaturation and 
the protein secondary structure is relatively stabilised. The 
presence of dithiothreitol (DTT)-induced reducing condi-
tions had little effect on the thermal denaturation profiles, 
though the spectral minima obtained at the initial 15 and 
30 °C were shallower than those obtained in the absence of 
Fig. 5  Expression and purification of  His6-tagged  VicKESD. a Solu-
ble and insoluble fractions of E. coli BL21 [DE3] cells harbouring 
pET14b-vicKESD were prepared by sonication of cell cultures and 
centrifugation at 100,000g for 40 min to sediment-insoluble material. 
Proteins were resolved using 12% SDS-polyacrylamide resolving gels 
and visualised with Coomassie Brilliant Blue stain. M: molecular 
mass markers; lane 1: uninduced insoluble fraction (20 μg); lane 2: 
induced insoluble fraction (20  μg); lane 3: induced soluble fraction 
(20 μg); and lane 4: uninduced soluble fraction (20 μg). b  His6-tagged 
 VicKESD was purified from E. coli soluble fractions using nickel 
affinity methods as described in “Materials and methods”, eluted 
with 200  mM sodium acetate pH 4.0 and exchanged into lane 1: 
20 mM Tris.HCl pH 7.9; lane 2: 20 mM sodium acetate pH 4.0; lane 
3: 20 mM sodium phosphate pH 7.2; or lane 4: 10 mM ammonium 
hydrogen carbonate pH 8.0 using Centricon-10  kDa filter devices; 
equivalent volumes of final ‘filtered’ protein solutions were analysed 
by SDS-PAGE and visualised using Coomassie Brilliant Blue stain-
ing. c Western blot analysis of purified  VicKESD, and soluble and 
insoluble fractions of E. coli BL21 [DE3]/pET14b-vicKESD lysates 
(30  μg protein). Proteins were transferred electrophoretically onto 
PVDF membrane and detected for the presence of a  His6 tag using an 
INDIA His probe followed by exposure to photographic film. Lane 1: 
uninduced insoluble fraction (20 μg); lane 2: induced insoluble frac-
tion (20 μg); lane 3: induced soluble fraction (20 μg); lane 4: unin-
duced soluble fraction (20 μg); and lane 5: purified  VicKESD (4 μg). 
M, molecular mass markers (the 75 kDa marker gives a positive sig-
nal with the His probe)
▸
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DTT, suggesting that the reducing agent may exert a small 
destabilising effect on  VicKESD secondary structural confor-
mation in the lower temperature range (Fig. 6b).
Discussion
At the 23rd International AUC Workshop & Symposium 
held at the University of Glasgow in July 2017, we reported 
the application of hydrodynamic methods using analytical 
ultracentrifugation (AUC) to characterise the enterococcal 
VanA-type VanS membrane protein and to explore the pos-
sibility that the glycopeptide antibiotic vancomycin binds to 
VanS directly, resulting in the activation of the VanSR two-
component signal transduction system for controlled expres-
sion of vancomycin resistance genes. AUC methods have 
been successfully applied previously for the study of integral 
membrane proteins and/or their supporting environments 
and for membrane-exporting proteins with high α-helical 
content (e.g. Schüler et al. 2000; Inagaki et al. 2013; Le Roy 
et al. 2015; Surya and Torres 2015; Xu et al. 2015; Lee et al. 
2016; Inagaki & Ghirlando 2017; Jaturontakul et al. 2017). 
We showed direct interactions by vancomycin with purified 
intact VanS (Fig. 7) (Phillips-Jones et al. 2017a, b), albeit 
weakly, as confirmed in our later study (Hughes et al. 2017). 
The hydrodynamics approach also revealed that under the 
Fig. 6  Thermal stability of 
 VicKESD in the presence and 
absence of dithiothreitol 
investigated by CD spectros-
copy. Purified  VicKESD (14 μM; 
0.25 mg/ml) in 10 mM sodium 
phosphate, pH 7.6, was used 
in far-UV measurements using 
2 nm bandwidth and 1 s/nm. 
Temperature ramping was 
between 15 and 90 °C. a For 15 
and 37 °C temperature points, 
30 repeat scans between 190 
and 260 nm were obtained. For 
comparisons of data obtained at 
the two temperatures, difference 
spectra were adjusted to the 
same values at 260 nm; b for 
other temperature points, five 
scans were obtained. Measure-
ments were obtained in the 
presence and absence of the 
reducing conditions of 137 μM 
or 5 mM dithiothreitol (DTT). 
Trough wavelength minima 
were determined experimentally 
(data not shown) to be 208 and 
222 nm and the spectral data at 
those minima are shown
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detergentless, membraneless conditions of our experiments, 
purified VanS remained monomeric even following vanco-
mycin binding. It is possible that to observe downstream 
changes in VanS following vancomycin binding (such as 
dimerization), the membrane environment is also required; 
our studies are now pursuing this possibility. VanS [which 
possesses only two predicted membrane-spanning regions 
(TMs)] was expressed using the membrane protein expres-
sion plasmid pTTQ18His in E. coli BL21 [DE3], also used 
for most of the other intact membrane proteins in this study. 
This system was employed here because it proved successful 
previously for the expression and subsequent purification 
of a large proportion of other enterococcal HPK membrane 
proteins (Ma et al. 2008). In the present study, we have 
established that this same host/plasmid system can also be 
used to express membrane proteins involved in vancomycin 
resistance and a truncated version of one of these proteins 
 VanTG-M possessing only the N-terminal l-serine mem-
brane transporter domain (and lacking the soluble C-termi-
nal serine racemase domain) (Meziane-Cherif et al. 2015). 
All four Van resistance membrane proteins investigated here, 
including the serine racemase  VanTG and its truncated ver-
sion  VanTG-M, were successfully expressed (Fig. 1). The 
location of the  His6 tags in all these recombinant proteins 
was predicted to be intracellular following the use of either 
pTTQ18His (which incorporates a C-terminal  His6 tag) for 
proteins with an even number of predicted TMs  (VanTG, 
 VanTG-M, VanS) or the use of the related plasmid pMR2 
(which introduces an N-terminal  His6 tag but is otherwise 
very similar to pTTQ18His) for VanZ, which has an une-
ven number of five predicted TMs. The adapted strategy 
described in the present study, which comprises routine use 
of LB broth for cell culturing, 1 mM inducer and a rapidly 
reduced post-induction temperature of 30 °C with no further 
optimisations of these conditions, proved successful, as all 
proteins were successfully expressed and located to and inte-
grated within E. coli membranes. If necessary, growth condi-
tions can be further optimised in future studies to increase 
the expression of these resistance proteins, but this proved 
unnecessary in the case of VanS purification for biophysical 
characterisation (Phillips-Jones et al. 2017a).
To the best of our knowledge, this is the first study to 
successfully express and purify the intact versions of the 
S. pneumoniae BlpH and ComD (pherotype 2) membrane 
sensor kinases. A previous study utilised domain fragments 
lacking the transmembrane domains (Sanchez et al. 2015). 
The successful expression and purification of these two 
membrane HPKs (Figs. 2, 3) adds to the high success rate 
of expressing members of this membrane protein family 
originating from Gram-positive species in the membranes 
of a Gram-negative E. coli host. A total of 15 out of the 
16 membrane HPKs from E. faecalis were successfully 
expressed previously, many of which were expressed using 
a strategy similar to that proposed here (Ma et al. 2008). In 
addition, 12 of the 15 expressed proteins were successfully 
purified (Ma et al. 2008). All purified HPKs tested so far, 
including ComD and BlpH in the present study, possessed 
structural integrity post-purification as revealed by far-UV 
CD spectroscopy (Fig. 4). In addition, purified ComD and 
BlpH interacted with and bound their peptide pheromone 
ligands CSP2 and BlpC, as revealed in the near-UV CD dif-
ference spectral measurements (Fig. 4). Together with pre-
vious successes in ligand binding studies using the same 
approach with other intact sensor kinases [e.g. FsrC (Patch-
ing et al. 2012) and VanS (Phillips-Jones et al. 2017a)], these 
results further strengthen the promise and potential of the 
in vitro approach described here for routine identification of 
ligands and ligand screening methods. Of particular inter-
est is the finding here that the CSP1 pheromone, as well as 
the native CSP2 ligand, interacted with ComD2 (Fig. 4d). 
CSP1 and CSP2 belong to two distinct and major pherotypes 
of S. pneumoniae (pherotypes 1 and 2, respectively) and 
are proposed to exhibit specific interactions only with their 
cognate ComD HPK of their respective pherotypes, thereby 
inducing competence for their own specific pherotype only 
(Pozzi et al. 1996; Iannelli et al. 2005; Johnsborg et al. 2006; 
Allan et al. 2007; Shpakov 2009). Consistent with that evi-
dence, it is possible that the binding to ComD shown in the 
present study by both CSPs (which exhibit approximately 
50% sequence identity) also occurs in vivo resulting in dif-
ferent conformational change outcomes (consistent with 
Fig. 4d data), with only that due to CSP2 binding resulting 
Fig. 7  Sedimentation coefficient concentration distribution, c(s) vs s 
profile for intact VanS (5.4 μM) (black line) in HGN buffer (contain-
ing 20% glycerol) pH ~ 7.9, I = 0.1, at 20.0  °C. The rotor speed was 
40,000 rpm. The profile for 12.8 μM vancomycin is shown (grey line). 
VanS and vancomycin is shown by the red line under the same condi-
tions. Reproduced with permission from Phillips-Jones et al. (2017a) 
Sci Rep 7:46,180
 European Biophysics Journal
1 3
in downstream activation of ComD and ComE and thence 
induction of competence. However, there are other possibili-
ties. For example, some S. pneumoniae strains/pherotypes 
have been reported to be inducible for competence by both 
CSP1 and CSP2 (Pozzi et al. 1996), which would suggest 
that strain ATCC 700669 used here might provide another 
example of such strains. Alternatively, it has been shown that 
high concentrations of non-cognate CSP1 can induce com-
petence in pherotype 2 strains in vitro (Iannelli et al. 2005). 
These possibilities are now being investigated.
The expression strategy described here was therefore suc-
cessfully applied for reliable expression of the membrane 
proteins reported here and we suggest that it can be used for 
expressing other members of these protein families without 
the need for further optimisations. Out of a total of 21 HPK 
membrane proteins attempted so far, 20 have been success-
fully expressed as intact proteins and 17 were successfully 
purified (Potter et al. 2002; Ma et al. 2008; Phillips-Jones 
et al. 2017a; and the present study). The adapted strategy 
is a modification of that originally proposed for bacterial 
transporter and other membrane proteins (Ward et al. 1999; 
Saidijam et al. 2003, 2005) and some of the key features are 
highlighted in the summary below:
1. Batch growth of at least 6 l of E. coli BL21 [DE3] host 
bacterium harbouring pTTQ18His or pMR2 expression 
plasmids with the cloned HPK gene. In our experience, 
the most suitable culturing conditions are aerobic cul-
turing in Luria–Bertani (LB) selective broth [without 
recourse to minimal or very rich media used previously 
for expression of members of some other membrane pro-
tein families, but which in our hands usually produces 
lower expression levels of HPKs (unpublished data)].
2. At mid-exponential phase, addition of 1 mM isopropyl-
thiogalactoside inducer of HPK gene expression, fol-
lowed by a rapid reduction in incubation temperature to 
30 °C. Post-induction incubation is usually of 3 h dura-
tion, but may benefit from longer time periods for some 
proteins. Cell harvesting by centrifugation and prepara-
tion of mixed E. coli membranes is as described in Ward 
et al. (1999).
3. Purification of  His6-tagged HPK proteins is by nickel 
affinity chromatography as described previously (Ward 
et al. 1999; Ma et al. 2008) using HEPES-based buffers 
containing 20% glycerol and 0.05% suitable detergent 
such as n-dodecyl-β-d-maltoside (DDM) in the pres-
ence of 20 mM imidazole in wash buffers and 200 mM 
imidazole in elute buffers. Sodium chloride is usually 
omitted. During buffer exchanges, the detergent concen-
tration is usually reduced to 0.025% which is still above 
the critical micelle concentration (CMC) value for DDM 
(0.17 mM or 0.0087%), yet retains the activity of most 
HPKs and their ability to dimerize upon ligand binding.
For many years, one of our main aims for expressing 
and purifying intact membrane HPKs, rather than domain 
fragments or soluble portions lacking the transmembrane 
regions, has been to investigate ligand (and inhibitor) bind-
ing and the ensuing downstream molecular events that then 
take place including transduction of the ligand signal (or 
inhibitor signal) across the membrane to the soluble domains 
within the cytoplasm involved in phosphorylation (Potter 
et al. 2002, 2006; Ma et al. 2008, 2011; Patching et al. 2012; 
Phillips-Jones et al. 2013, 2017a, b). The approach seems 
logical given that the sensory domains are often located 
within the transmembrane segments. Yet, such an approach 
applied to membrane sensor kinases is in some cases much 
more challenging to undertake than for the more hydro-
phobic membrane transport proteins for which detergent 
is absolutely essential to maintain solubility and function. 
Membrane sensor kinases may possess as few as two trans-
membrane segments with a much larger soluble portion 
comprising the kinase and ATP-binding domains that reside 
in the cytoplasm in vivo. The two predicted transmembrane 
segments of the A-type VanS make up just 10.8% of the 
protein. Therefore, for functional studies the large soluble 
portion as well as the ‘minor’ hydrophobic portion of the 
transmembrane domain must both be considered. Solubility 
trials often influence how to proceed—for VanS, solubility 
was often better when detergent was omitted post-elution 
(Phillips-Jones et al. 2017a). Use of detergent-less buffers 
facilitated identification by hydrodynamic methods of van-
comycin as a ligand; binding was observed in the absence of 
detergent. Indeed, VanS by itself had a symmetry of 12:1 in 
aqueous solvent which then became 5:1 in the presence of 
ligand, suggesting a significant conformational change and 
possibly behaviour reminiscent of intrinsic disorder proteins 
in aqueous solution (Dunker et al. 2002). But the accom-
panying dimerization event was lacking (Phillips-Jones 
et al. 2017b), though the protein was shown to be active in 
activity-based buffers (Phillips-Jones et al. 2017a, b). So, 
perhaps a detergent or a membrane environment is required 
after all to observe some events, though in our experience 
the presence of detergent usually reduces or abolishes HPK 
autophosphorylation activities. In any case, in the example 
of VanS in the absence of detergent, ligand identification was 
successfully achieved.
Another approach for investigations of ligand binding 
by membrane HPKs is to clone and express the predicted 
sensing domains in isolation, without the TMs. If the sens-
ing domain is sufficiently large, then this eliminates the 
challenges posed by the hydrophobic full-length mem-
brane proteins and studies can be pursued in the absence 
of added detergent. It assumes, however, that the TMs are 
not involved in the sensing mechanism. This approach was 
successfully used recently in studies of YycG-ex, the extra-
cellular sensing domain of the S. aureus VicK homologue, 
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YycG. The crystal structure of YycG-ex was determined 
and proved insightful for determining how the intact protein 
functions (Kim et al. 2016). Adopting a similar approach 
here for E. faecalis  VicKESD, which possesses a predicted 
sensing domain of 141 residues, the sensing domain was 
successfully overexpressed as a recombinant His-tagged 
soluble protein of 162 residues (lacking the fMet) and 
approximately 18 kDa (Fig. 5). The purified protein retained 
structural integrity post-purification and was soluble at con-
centrations of up to 19 mg/ml suitable for crystallisation and 
other structural studies. The domain was overall α-helical 
and exhibited some denaturation upon increases in tempera-
ture from 15 to 50 °C, as revealed through measurements of 
secondary structure composition, but at > 50 °C structural 
integrity remained relatively stable (Fig. 6).
Conclusion
For successful and routine expression in E. coli of intact bac-
terial histidine kinase and vancomycin resistance membrane 
proteins, an adapted strategy of the methods described by 
Ward et al. (1999) and Saidijam et al. (2005), and described 
in the present study was shown to be sufficient to obtain 
the expression of all these membrane proteins. Further opti-
misations can then be undertaken to maximise membrane 
protein production, but for the proteins tested here no further 
optimisations were necessary for obtaining sufficient puri-
fied proteins for downstream biophysical characterisations, 
including identification and confirmation of ligand interac-
tions by ComD and BlpH. Expression of sensing domains 
in isolation may be another useful approach for producing 
members of these protein families.
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